The abstract is read at the publisher; the summary is JClub's.
Endogenous opioid signaling by enkephalins and dynorphins is temporally dynamic, circuit-specific, and functionally heterogeneous, challenging simple reward-versus-aversion dichotomies.
- Why it matters: The field lacks a circuit- and context-aware account of how these peptides regulate both rewarding and aversive behaviors.
- What they did: This review synthesizes methodological advances enabling in vivo measurement and manipulation of endogenous opioid signaling at behaviorally relevant timescales, framed around the nucleus accumbens–ventral pallidum–ventral tegmental area circuit.
- The result: The evidence implies that dynorphin and enkephalin roles depend on timing and neural circuitry, reshaping models of how reward and aversion are controlled.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.